Page last updated: 2024-11-01

nimodipine and Periphlebitis

nimodipine has been researched along with Periphlebitis in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Periphlebitis: Periphlebitis is inflammation of the outer coat of a vein or of tissues surrounding the vein.

Research Excerpts

ExcerptRelevanceReference
" The physical compatibility, pharmacokinetic, and vascular irritability studies showed that, in comparison to the commercially available NIM injections, NIM-EPC-SGC-MMs presented better physical compatibility, the same pharmacokinetic profile, and less risk of local vascular irritation and phlebitis."1.38Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study. ( Gong, T; Jiang, Y; Ren, C; Song, X; Sun, X; Zhang, Q; Zhang, Z, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Song, X1
Jiang, Y1
Ren, C1
Sun, X1
Zhang, Q1
Gong, T1
Zhang, Z1

Other Studies

1 other study available for nimodipine and Periphlebitis

ArticleYear
Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Animals; Drug Stability; Ear; Edema; Glycocholic Acid; Hydrogen-Ion Concentration; Male; Micelles; N

2012